CIK 0001388658 · Large accelerated filer
iRhythm Holdings, Inc.
Sign in to watch- Ticker
- IRTC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 413421287
- Phone
- 415-632-5700
- Business address
- 699 8TH STREET, SUITE 600, San Francisco, CA, 94103
- Former names
- IRhythm Technologies, Inc., iRhythm Technologies, Inc., IRhythm Technologies Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $94,175
- in 1 filing
Net −$94,175. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-06 | Patterson Chad Chief Commercial Officer | Sale 10b5-1 | −2,555 | $158.97 | $406K | 43,667 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −8,726 | $158.85 | $1.4M | 200,312 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −9,775 | $160.06 | $1.6M | 190,537 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −4,905 | $160.73 | $788K | 185,632 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −1,600 | $161.92 | $259K | 184,032 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −1,514 | $163.30 | $247K | 182,518 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −3,174 | $163.93 | $520K | 179,344 |
| 2025-08-05 | Blackford Quentin S. President and CEO | Sale 10b5-1 | −306 | $165.00 | $50K | 179,038 |
| 2025-08-04 | Smith Mervin EVP Strategic Business Ops | Sale | −616 | $164.36 | $101K | 15,838 |
| 2025-08-04 | Patterson Chad Chief Commercial Officer | Sale | −2,707 | $164.36 | $445K | 46,222 |
| 2025-07-07 | MCGINNIS KAREN K Director | Grant or award | +2,035 | 2,035 | ||
| 2025-07-07 | OBOYLE KEVIN C Director | Grant or award | +2,035 | 2,035 | ||
| 2025-07-02 | Turakhia Minang EVP, CMO & CSO | Sale | −1,420 | $145.41 | $206K | 41,393 |
| 2025-07-01 | Freeman Sean Clinton EVP, Strategy & Corp Devt | Grant or award | +6,761 | 6,761 | ||
| 2025-06-23 | Wilson Daniel G. Chief Financial Officer | Sale 10b5-1 | −3,000 | $150.00 | $450K | 40,307 |
| 2025-06-23 | Patterson Chad Chief Commercial Officer | Sale 10b5-1 | −936 | $150.00 | $140K | 48,929 |
| 2025-06-10 | Patterson Chad Chief Commercial Officer | Sale 10b5-1 | −363 | $150.00 | $54K | 49,865 |
| 2025-06-02 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale | −1,608 | $140.21 | $225K | 34,685 |
| 2025-06-02 | Rosenbaum Marc W. Chief Accounting Officer | Sale | −696 | $140.21 | $98K | 11,105 |
| 2025-05-30 | Shrishrimal Sumi EVP, Chief Risk Officer | Grant or award | +176 | $71.46 | $13K | 36,293 |
Page 7 of 8 · 159 trades